Intersect ENT Receives $30,000,000 Series C Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=82249051-73d6-493b-b231-d55d45ec7398&Preview=1 - Date
11/2/2010 - Company Name
Intersect ENT - Mailing Address
1049 Elwell Court Palo Alto, CA 94303 - Company Description
Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose & Throat surgeons to utilize in providing improved treatment for their patients. - Website
http://www.intersectent.com - Transaction Type
Venture Equity - Transaction Amount
$30,000,000 - Transaction Round
Series C - Proceeds Purposes
Intersect ENT intends to use the proceeds to commercialize its initial product as well as build a portfolio of products for conditions treated by Ear, Nose, & Throat (ENT) surgeons. - M&A Terms
- Venture Investor
Medtronic - Venture Investor
PTV Sciences - Venture Investor
Kleiner Perkins Caufield & Byers - Venture Investor
U.S. Venture Partners
